Edition:
United Kingdom

People: Piramal Enterprises Ltd (PIRA.NS)

PIRA.NS on National Stock Exchange of India

1,872.85INR
23 Jul 2019
Change (% chg)

-- (--)
Prev Close
Rs1,872.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
879,239
52-wk High
Rs3,307.95
52-wk Low
Rs1,705.50

Sharma, Vivek 

Mr. Vivek Sharma serves as Chief Executive Officer - Pharma Solutions of the company. He is currently serves as the CEO of Piramal Pharma Solutions (PPS), a global leader in providing Contract Research, Development and Manufacturing services towards the life sciences industry. PPS offers integrated solutions from discovery through development and commercialisation, with research and manufacturing facilities in North America, Europe, and Asia. Under his leadership, PPS has been voted ‘global top 10% CMO’ for 2014 and 2015. He started his stint in the Piramal Group by heading the Piramal Critical Care (PCC) business and was instrumental in improving profitability and establishing it as the third largest and the fastest growing Inhalation Anesthetics company globally. Prior to Piramal, Mr. Sharma was Managing Director at THL Partners, a Boston based global private equity fund, and has held senior leadership positions in Finance and Operations at AMD and Motorola. He was recently awarded the ‘CEO Of The Year’ at CPhi 2015 and has been listed among ‘the top 100 finance professionals in the United States’. He is based out of Boston and is a Chartered Accountant from India. Besides, he is a qualified CPA, and holds a Masters in International Business from Thunderbird School of Management.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --